More on UTHR

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-13.3% Growth)
- Ratings (6.2 Score)
- Holders
- Event Driven Deals

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (11/4/26)
- M&A (9/30/18 *Est)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

United Therapeutics (NQ:UTHR)
Delayed: 590.86 +3.36 (0.57%)
Prev. Close $587.50  
Open$589.11 
52 Wk High$164.04 
52 Wk Low$97.52 
Day High$592.56 
Day Low$584.50 
P/E 108.02  
EPS$5.47 
Volume118,763 

Friends, Peers and Foes (?): LQDA, INSM, JAZZ, MIRM, BIOS (more...)

Oct 26, 2026 10:19 AM United Therapeutics Corp. (UTHR) PT Raised to $850 at Cantor Fitzgerald
Oct 23, 2026 04:35 PM Form 4 UNITED THERAPEUTICS Corp For: Oct 22 Filed by: ROTHBLATT MARTINE A
Oct 22, 2026 04:36 PM Form 4 UNITED THERAPEUTICS Corp For: Oct 21 Filed by: ROTHBLATT MARTINE A
Oct 22, 2026 07:14 AM United Therapeutics Corp. (UTHR) PT Lowered to $697 at RBC Capital
Oct 22, 2026 07:00 AM Form 8-K UNITED THERAPEUTICS Corp For: Oct 21
Oct 22, 2026 07:00 AM United Therapeutics authorizes $2 billion share repurchase program
Oct 22, 2026 07:00 AM United Therapeutics Corporation Announces Additional $2 Billion Share Repurchase Authorization
Oct 21, 2026 04:34 PM Form 4 UNITED THERAPEUTICS Corp For: Oct 20 Filed by: ROTHBLATT MARTINE A
Oct 21, 2026 07:00 AM United Therapeutics Corporation to Report Third Quarter 2026 Financial Results Before Market Open on Wednesday, November 4, 2026
Oct 20, 2026 04:36 PM Form 4 UNITED THERAPEUTICS Corp For: Oct 19 Filed by: ROTHBLATT MARTINE A
View All Articles

Entities mentioned with UTHR

View All Entities